Daily Recap - WEDNESDAY
Join panelists Drs. Janet Pope, Richard Conway, Meral El Ramahi and Jack Cush recap the best presentations presented on day four of the 2023 ACR Convergence meeting in San Diego, CA.
Watch video →What's hot
View all perspectives
What's Hot
EXXELERATE Study: Do High RF Titers Impact Response to TNF Inhibitors?
Dr. Jonathan Kay discusses abstract 2148 with Dr. Josef Smolen at the 2023 ACR Convergence meeting in San Diego, CA.
Watch video →
Bimekizumab in Active AS: 5 Year Study
Dr. Atul Deodhar reporting on abstract 0519 from the 2023 ACR Convergence meeting in San Diego, CA.
Watch video →
Cannabinoid Receptor in RA Patients
Dr. Arthur Kavanaugh discusses abstract 0025 at the 2023 ACR Convergence meeting in San Diego, CA.
Watch video →
Treatments in SpA
Dr. Rachel Tate and Dr. Catherine Blakewell discuss treatment options patients in spondyloarthritis at the 2023 ACR Convergence meeting in San Diego, CA. Abstracts discussed include 0520, 0530, 0521 and 0529.
Watch video →
PR3+ in Lupus Nephritis
Dr. Jack Cush discusses abstract 2427 presented at the 2023 ACR Convergence meeting in San Diego, CA.
Watch video →
Simulated Trials to Counter ORAL Survelliance
Dr. Jack Cush and Dr. Janet Pope at the 2023 ACR Convergence meeting in San Diego, CA.
Watch video →
Difficult to Treat axSpA
Dr. Peter Nash reports on abstracts 0514 and 0538 from the 2023 ACR Convergence meeting in San Diego, CA.
Watch video →
Window of Opportunity in PsA
Dr. Peter Nash discusses a study that looks at the window of opportunity for treatment of PsA at the 2023 ACR Convergence meeting in San Diego, CA.
Watch video →
TMP SMX Prophylaxis in GPA
Dr. Jack Cush and Dr. Janet Pope discuss abstract 1584 presented at the 2023 ACR Convergence meeting in San Diego, CA.
Watch video →
The FOREMOST Study: Apremilast in PsA
Dr. Peter Nash reports on abstract 1691 presented at the 2023 ACR Convergence meeting in San Diego, CA.
Watch video →
The SMART Study: Split Dose Oral Methotrexate
Dr. Jack Cush discusses abstract 1583 presented at the 2023 ACR Convergence meeting in San Diego.
Watch video →
Real World Experience with PEXIVAS Low Steroid Taper
Dr. Mike Putman discusses abstract 0725 with Dr. Sophie Nagle at the 2023 ACR Convergence meeting in San Diego, CA.
Watch video →
Cancer and TNF inhibitors
Cancer risk minimisation is a high priority for people with rheumatic diseases, as it is for the general population. Tumor necrosis factor inhibitors (TNFi) have a long history of association with cancer risk discussions. An oral presentation by Suarez-Almazor et al provided more supportive data on using TNFi in this population.
Read more →
#ACRbest Abstracts – Day 2
Our reporters have been prolific in finding the hot abstracts, those that were most attended or those that are getting the most buzz on social media. Here are RheumNow's #ACRbest abstract reports from Monday, November 13, 2023 at #ACR23, covering The Great Debate, SGLPT2 inhibitors in SLE, the SMART Study of MTX, TMP/SMX Prophylaxis, RA-ILD & TNF Inhibitors, cancer research and more.
Read more →
Effects of Apremilast on Cardiometabolic Effects in PsA
Dr. Peter Nash discusses abstract 1414 at the 2023 ACR Convergence meeting in San Diego, CA.
Watch video →
An Interview with Kevin Winthrop: Three Questions About COVID 19
Drs. Jack Cush and Kevin Winthrop discuss COVID 19 at 2023 ACR Convergence in San Diego, CA.
Watch video →
Biologics as First-line Therapy for PMR and GCA?
Dr. Eric Dein talks with Dr. Philip Seo, one of two panelists for the Great Debate: Should PMR and GCA Be Treated with Advanced Therapies at Disease Onset? at the 2023 ACR Convergence meeting in San Diego, CA.
Watch video →
Dr. Antoni Chan
2 years ago
New clinical skill to use in the clinic. Auscultate at the TMJ for crepitus and measure the maximal incisal opening in JIA, Sadun R, #ACR23 @RheumNow https://t.co/8koZRCZYoP
Dr. John Cush RheumNow
2 years ago
OA and Syncope
OA patient on NSAIDs presents with a peptic ulcer and GI Bleed.
https://t.co/ezMbqgAB0Q https://t.co/iutdfUAPv2
Alberta Rheumatology RheumAb
2 years ago
Hey #ACR23!
Need a theme song for rheumatology?
Because #Rheum makes your hands clap!
https://t.co/vKYOH8zdIv
@chroniceileen @realcc @ACRheum @ACRSimpleTasks #RheumTwitter @CRASCRRheum @RheumNow @rheumpatient @RNSociety @ArthritisFdn @VersusArthritis @exerciseworks #arthritis
Dr. Antoni Chan
2 years ago
Keeping the eyes 👀 on the target. Early start to the day with the ACR review course on the eye 👁️ in rheumatic disease. Causes of uveitis #ACR23 @RheumNow https://t.co/g5y5Vs01RX
TheDaoIndex KDAO2011
2 years ago
ID testing for pts with inflammatory eye disease: syphilis, TB, Lyme (where appropriate). Low yield is toxoplasma, toxocara and viral dz - Dr L Kopplin #ACRReview
@RheumNow #ACR23 https://t.co/UyQ8Bc2cEy
Mike Putman EBRheum
2 years ago
Super fun meeting with fellows for the annual FIT session yesterday!
Thanks to everyone who came to my table for the expensive FedEx'ed handouts 😂
Here's a link to a PDF & pics if anyone is interested in the handout!
@RheumNow #ACR23
https://t.co/kh7sOh2BWj https://t.co/DoEZzHSaAp
Dr. John Cush RheumNow
2 years ago
Join us tomorrow! We’ll be hosting a LIVE #ACR23 recap. https://t.co/DxdsaPgRfC
Dr. John Cush RheumNow
2 years ago
Join us tonight for our first daily #ACR23 recap! LIVE! https://t.co/jIfrqQXxdY
Dr. John Cush RheumNow
2 years ago
Rheumatoid Synovium Characterized by Six Cell Type Phenotypes
Could CTAPs known disease features or more effective future therapies?
https://t.co/mcbNAO7lAQ https://t.co/wiOW8Xq0mI
Nouf Al hemmadi
2 years ago
ACR convergence highlights by the awesome, i mean very awesome team @RheumNow
Sunday to Thursday with recap Friday 🤓 i am stocking every one😂
https://t.co/WahAoH7MCM
Biologic / target synthetic induced None melanoma skin cancer? Disease induced or medication induced ?
Dr. John Cush RheumNow
2 years ago
RheumNow’s expanded coverage of the #ACR23 annual meeting is sponsored in part by Bristol Myers Squibb and UCB. All content is chosen by RheumNow & its faculty.
Dr. John Cush RheumNow
2 years ago
Arthritis Increased Amongst US Veterans
An updated report shows a larger number (~33%) of U.S. veterans having diagnosed arthritis. Compared to nonveterans, this prevalence was double in men, and 60% higher in women.
https://t.co/9sAaxrxWEP https://t.co/gEj7g8ahdk
Dr. John Cush RheumNow
2 years ago
Habitually Noncompliant
Seronegative RA - No Show, Won't Go, prn Patient
QD Clinics are sponsored by RheumNows Coverage of #ACR23 live from San Diego
https://t.co/jeD3H9RHvs https://t.co/zIEkecPEu0
Dr. John Cush RheumNow
2 years ago
RheumNow’s expanded coverage of the #ACR23 Annual meeting is sponsored in part by Novartis. All content is chosen by RheumNow & its faculty
Dr. John Cush RheumNow
2 years ago
AI Can Predicts Radiographic Change in RA
The ACR has published a preview of new research from #ACR23 showing that AI & a deep learning system could accurately identify & predict joint space narrowing and erosions in hand radiographs of patients w/ RA.
https://t.co/GGplIcyZLk https://t.co/CVhZfR4gCj
Poster Hall